Latest Insider Transactions at Processa Pharmaceuticals, Inc. (PCSA)
This section provides a real-time view of insider transactions for Processa Pharmaceuticals, Inc. (PCSA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Processa Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Processa Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 27
2023
|
James R Neal |
BUY
Exercise of conversion of derivative security
|
Direct |
14,407
+50.0%
|
-
|
|
Jun 27
2023
|
Khoso Baluch |
BUY
Exercise of conversion of derivative security
|
Direct |
15,455
+35.6%
|
-
|
|
Jun 27
2023
|
Virgil Thompson |
BUY
Exercise of conversion of derivative security
|
Indirect |
23,636
+16.03%
|
-
|
|
Jun 27
2023
|
Geraldine Pannu |
BUY
Exercise of conversion of derivative security
|
Direct |
23,636
+30.8%
|
-
|
|
Jun 12
2023
|
David Young Pres. Research & Development |
BUY
Open market or private purchase
|
Direct |
40,000
+7.84%
|
$0
$0.8 P/Share
|
|
Apr 14
2023
|
David Young Pres. Research & Development |
BUY
Open market or private purchase
|
Direct |
20,000
+4.44%
|
$0
$0.55 P/Share
|
|
Apr 13
2023
|
David Young Pres. Research & Development |
BUY
Open market or private purchase
|
Direct |
20,000
+4.65%
|
$0
$0.48 P/Share
|
|
Apr 12
2023
|
David Young Pres. Research & Development |
BUY
Open market or private purchase
|
Direct |
20,000
+4.87%
|
$0
$0.45 P/Share
|
|
Apr 11
2023
|
David Young Pres. Research & Development |
BUY
Open market or private purchase
|
Direct |
20,000
+5.12%
|
$0
$0.52 P/Share
|
|
Feb 09
2023
|
James H Stanker Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+16.84%
|
$0
$0.8 P/Share
|
|
Feb 09
2023
|
Robert Michael Floyd Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+10.84%
|
$0
$0.8 P/Share
|
|
Feb 09
2023
|
Khoso Baluch |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+50.0%
|
$0
$0.8 P/Share
|
|
Feb 09
2023
|
David Young Pres. Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
18,750
+5.08%
|
$0
$0.8 P/Share
|
|
Feb 09
2023
|
Patrick Lin Chief Business - Strategy Off |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+2.7%
|
$0
$0.8 P/Share
|
|
Dec 31
2022
|
Justin W Yorke |
BUY
Grant, award, or other acquisition
|
Direct |
18,208
+35.49%
|
-
|
|
Dec 31
2022
|
Geraldine Pannu |
BUY
Exercise of conversion of derivative security
|
Direct |
18,208
+38.18%
|
-
|
|
Dec 31
2022
|
Virgil Thompson |
BUY
Exercise of conversion of derivative security
|
Indirect |
18,208
+15.38%
|
-
|
|
Oct 06
2022
|
Robert Michael Floyd Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,163
-5.45%
|
-
|
|
Oct 06
2022
|
Robert Michael Floyd Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+14.06%
|
-
|
|
Aug 16
2022
|
David Young Pres. Research & Development |
SELL
Bona fide gift
|
Direct |
9,250
-2.39%
|
-
|
|
Aug 16
2022
|
Robert Michael Floyd Chief Operating Officer |
SELL
Bona fide gift
|
Direct |
7,000
-9.87%
|
-
|
|
Aug 05
2022
|
James H Stanker Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,462
-4.76%
|
$7,386
$3.17 P/Share
|
|
Aug 05
2022
|
James H Stanker Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,601
+12.82%
|
-
|
|
Aug 05
2022
|
David Young Pres. Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
2,531
-0.65%
|
$7,593
$3.17 P/Share
|
|
Aug 05
2022
|
David Young Pres. Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
7,601
+1.91%
|
-
|
|
Aug 05
2022
|
Virgil Thompson |
BUY
Exercise of conversion of derivative security
|
Direct |
1,169
+6.54%
|
-
|
|
Aug 05
2022
|
Geraldine Pannu |
BUY
Exercise of conversion of derivative security
|
Direct |
1,169
+9.4%
|
-
|
|
Aug 05
2022
|
Patrick Lin Chief Business - Strategy Off |
SELL
Payment of exercise price or tax liability
|
Direct |
2,656
-0.6%
|
$7,968
$3.17 P/Share
|
|
Aug 05
2022
|
Patrick Lin Chief Business - Strategy Off |
BUY
Exercise of conversion of derivative security
|
Direct |
7,601
+1.69%
|
-
|
|
Aug 05
2022
|
Wendy Guy Chief Administrative Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,601
+3.86%
|
-
|
|
Aug 05
2022
|
Sian Bigora Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,601
+1.85%
|
-
|
|
May 17
2022
|
Patrick Lin Chief Business - Strategy Off |
BUY
Open market or private purchase
|
Direct |
2,000
+0.46%
|
$2,000
$1.59 P/Share
|
|
Apr 07
2022
|
Patrick Lin Chief Business - Strategy Off |
BUY
Open market or private purchase
|
Direct |
800
+0.19%
|
$2,400
$3.54 P/Share
|
|
Apr 06
2022
|
Patrick Lin Chief Business - Strategy Off |
BUY
Open market or private purchase
|
Direct |
1,200
+0.28%
|
$3,600
$3.13 P/Share
|
|
Mar 31
2022
|
Justin W Yorke |
BUY
Grant, award, or other acquisition
|
Direct |
8,786
+24.26%
|
-
|
|
Mar 31
2022
|
Virgil Thompson |
BUY
Grant, award, or other acquisition
|
Direct |
4,393
+20.83%
|
-
|
|
Mar 31
2022
|
Geraldine Pannu |
BUY
Grant, award, or other acquisition
|
Direct |
4,393
+30.31%
|
-
|
|
Mar 31
2022
|
Khalid Islam Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,392
+5.71%
|
-
|
|
Mar 31
2022
|
Robert Michael Floyd Chief Operating Officer |
SELL
Bona fide gift
|
Direct |
7,000
-8.98%
|
-
|
|
Jan 27
2022
|
Justin W Yorke |
SELL
Open market or private sale
|
Indirect |
1,854
-0.35%
|
$5,562
$3.3 P/Share
|
|
Dec 14
2021
|
Patrick Lin Chief Business - Strategy Off |
BUY
Open market or private purchase
|
Direct |
6,000
+0.69%
|
$24,000
$4.0 P/Share
|
|
Dec 06
2021
|
Justin W Yorke |
SELL
Open market or private sale
|
Indirect |
4,200
-0.78%
|
$16,800
$4.71 P/Share
|
|
Dec 03
2021
|
Patrick Lin Chief Business - Strategy Off |
BUY
Open market or private purchase
|
Direct |
3,500
+0.81%
|
$14,000
$4.8 P/Share
|
|
Dec 03
2021
|
Justin W Yorke |
SELL
Open market or private sale
|
Indirect |
5,500
-1.01%
|
$22,000
$4.84 P/Share
|
|
Oct 06
2021
|
Robert Michael Floyd Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,663
-33.19%
|
-
|
|
Oct 06
2021
|
Robert Michael Floyd Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+46.3%
|
-
|
|
Aug 26
2021
|
Patrick Lin Chief Business - Strategy Off |
BUY
Open market or private purchase
|
Direct |
4,000
+0.94%
|
$24,000
$6.02 P/Share
|
|
Aug 05
2021
|
Wendy Guy Chief Administrative Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,036
-1.08%
|
$16,144
$4.69 P/Share
|
|
Aug 05
2021
|
David Young Pres. Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
7,601
+1.95%
|
-
|
|
Aug 05
2021
|
Virgil Thompson |
BUY
Grant, award, or other acquisition
|
Direct |
1,169
+8.68%
|
-
|